Cite

HARVARD Citation

    D'Argenio, V. et al. (2014). Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?. Cancer. 120 (10), pp. 1594-1595. [Online]. 
  
Back to record